AstraZeneca (AZN) growth opportunities 'overlooked' - Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to AstraZeneca (AZN) growth opportunities 'overlooked' - Jefferies
September 25, 2023 7:58 AM EDT
Investing.com -- U.S. futures edged lower Monday, with investors still reeling from last weeks hawkish Federal Reserve meeting, while a U.S. government shutdown draws nearer.
Here are some of the biggest premarket U.S. stock movers today:
Amazon (NASDAQ: AMZN) stock rose 0.5% after the tech giant announced plans to invest up to $4... More
September 25, 2023 3:20 AM EDT
Jefferies analyst Peter Welford upgraded AstraZeneca (NASDAQ: AZN) from Neutral to Buy with a price target of $80.00 (from $66.50).
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $67.83 yesterday.
...
More
September 25, 2023 2:59 AM EDT
Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating and GBP110.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).
...
More
September 25, 2023 2:44 AM EDT
Berenberg lowered its price target on AstraZeneca (NASDAQ: AZN) to $81.70 (from $83.90) while maintaining a Buy rating.... More
September 25, 2023 2:42 AM EDT
Berenberg analyst Luisa Hector reiterated a Buy rating and GBP133.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).
...
More
September 24, 2023 9:22 PM EDT
Jefferies analyst Peter Welford upgraded AstraZeneca (AZN:LN) (NASDAQ: AZN) from Hold to Buy with a price target of GBP130.00 (from GBP105.00).
...
More
September 23, 2023 8:01 AM EDT
Morgan Stanley analyst Mark Purcell reiterated an Overweight rating and GBP127.00 price target on AstraZeneca (AZN:LN) (NASDAQ: AZN).
...
More
